Abstract
Constitutive NF-κB activity varies widely among cancer cell lines. In this report, we studied the expression and the role of different IκB inhibitors in adenocarcinoma cell lines. High constitutive NF-κB activity and low IκB-α expression was found in a number of these cell lines. Moreover, some of these cells showed a high p100 expression, responsible for the cytoplasmic sequestration of most of p65 complexes. Treatment of these cells with TNF-α or other NF-κB activating agents induced only weakly nuclear NF-κB activity without significant p100 processing and led to a very weak transcription of NF-κB-dependent reporter gene. Induction of NF-κB activity can be restored by expression of the Tax protein or by treatment with antisense p100 oligonucleotides. In MCF7 A/Z cells stably transfected with a p100 expression vector, p65 complexes were sequestered in the cytoplasm by p100. These cells showed a reduced nuclear NF-κB induction and NF-κB-dependent gene transcription following TNF-α stimulation. As a consequence of a competition between IκB-α and p100, cells expressing high levels of p100 respond poorly to NF-κB activating stimuli as TNF-α.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abmayr SM and Workman JL. . 1990 Curr. Protocol Molec. Biol. Greene Publishing Associates: New York 12.1.1–12.1.9.
Alkalay I, Yaron A, Hatzubai A, Orian A and Ciechanover A. . 1995 Proc. Natl. Acad. Sci. USA 92: 10599–10603.
Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D and Hay RT. . 1995 Mol. Cell. Biol. 15: 2689–2696.
Baldwin AS. . 1996 Annu. Rev. Immunol. 14: 649–681.
Bargou RC, Emmerich F, Krappmann D, Bomert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C and Dörken B. . 1997 J. Clin. Invest. 100: 2961–2969.
Bargou RC, Leng C, Krappmann D, Mapara MY, Emmerich F, Bommert K, Scheidereit C and Dörken B. . 1996 Blood 87: 4340–4347.
Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA and Baldwin ASJ. . 1992 Genes Dev. 6: 1899–1913.
Beg AA, Sha WC, Bronson RT and Baltimore D. . 1995 Genes Dev. 9: 2736–2746.
Betts JC and Nabel GJ. . 1996 Mol. Cell. Biol. 11: 6363–6371.
Bitar R, Beauparlant P, Lin R, Pitha P and Hiscott J. . 1995 Cell Growth Differ. 6: 965–976.
Bours V, Azarenko V, Dejardin E and Siebenlist U. . 1994 Oncogene 9: 1699–1702.
Bours V, Burd PR, Brown K, Villalobos J, Park S, Ryseck R-P, Bravo R, Kelly K and Siebenlist U. . 1992 Mol. Cell. Biol. 12: 685–695.
Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K and Siebenlist U. . 1993 Cell 72: 729–739.
Bours V, Villalabos J, Burd PR, Kelly K and Siebenlist U. . 1990 Nature 348: 76–80.
Brown K, Gerstberger S, Carlson L, Franzoso G and Siebenlist U. . 1995 Science 267: 1485–1488.
Brown K, Park S, Kanno T, Franzoso G and Siebenlist U. . 1993 Proc. Natl. Acad. Sci. USA 90: 2532–2536.
Caamano JH, Rizzo CA, Durham SK, Barton DS, Raventos-Suàrez C, Snapper CM and Bravo R. . 1998 J. Exp. Med. 187: 185–196.
Chang CC, Zhang J, Lombardi L, Neri A and Dalla-Favera R. . 1995 Mol. Cell. Biol. 15: 5180–5187.
Chen Z, Hagler J, Palombella V, Melandri F, Scherer D, Ballard D and Maniatis T. . 1995 Genes Dev. 9: 1586–1597.
Dejardin E, Bonizzi G, Bellahcène A, Castronovo V, Merville M-P and Bours V. . 1995 Oncogene 11: 1835–1841.
Dejardin E, Deregowski V, Greimers R, Cai Z, Chouaib S, Merville M-P and Bours V. . 1998 Oncogene 16: 3299–3307.
DiDonato J, Mercurio F, Rosette C, Wu-Li J, Suyang H, Ghosh S and Karin M. . 1996 Mol. Cell. Biol. 16: 1295–1304.
Dobrzanski P, Ryseck R-P and Bravo R. . 1994 EMBO J. 13: 4608–4616.
Dobrzanski P, Ryseck R-P and Bravo R. . 1995 Oncogene 10: 1003–1007.
Fan C-M and Maniatis T. . 1991 Nature 354: 395–398.
Fracchiola N, Lombardi L, Salina M, Miglazza A, Baldini L, Berti E, Cro L, Polli E, Maiolo AT and Neri A. . 1993 Oncogene 8: 2839–2845.
Franzoso G, Bours V, Azarenko V, Park S, Tomita-Yamaguchi M, Kanno T, Brown K and Siebenlist U. . 1993 EMBO J. 12: 3893–3901.
Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K and Siebenlist U. . 1992 Nature 359: 339–342.
Franzoso G, Carlson L, Poljak L, Shores EW, Epstein S, Leonardi A, Grinberg A, Tran T, Scharton-Kersten T, Anver M, Love P, Brown K and Siebenlist U. . 1998 J. Exp. Med. 187: 147–159.
Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown K, Leonardi A, Tran T, Boyce BF and Siebenlist U. . 1997 Genes Dev. 11: 3482–3496.
Fujita T, Nolan GP, Liou H-C, Scott ML and Baltimore D. . 1993 Genes Dev. 7: 1354–1363.
Ganchi PA, Sun S-C, Greene WC and Ballard DW. . 1992 Mol. Biol. Cell 3: 1339–1352.
Good L and Sun S-C. . 1996 J. Virol. 70: 2730–2735.
Haskill S, Beg AA, Tompkins SM, Morris JS, Yurochko AD, Sampson-Johannes A, Mondal K, Ralph P and Baldwin ASJ. . 1991 Cell 65: 1281–1289.
Henkel T, Zabel U, van Zee K, Muller JM, Fanning E and Baeuerle PA. . 1992 Cell 68: 1121–1133.
Hiscott J, Petropoulos L and Lacoste J. . 1995 Virology 214: 3–11.
Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB-M, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA and Peyron J-F. . 1996 Cell 86: 787–798.
Iotsova V, Caamano J, Loy J, Yang Y, Lewin A and Bravo R. . 1997 Nature Med. 3: 1285–1289.
Ishikawa H, Carrasco D, Claudio E, Ryseck R-P and Bravo R. . 1997 J. Exp. Med. 186: 999–1014.
Kalkhoven E, Wissink S, van der Saag PT and van der Burg B. . 1996 J. Biol. Chem. 271: 6217–6224.
Kanno T, Franzoso G and Siebenlist U. . 1994 Proc. Natl. Acad. Sci. USA 91: 12634–12638.
Kieran M, Blank V, Logeat F, Vandekerckhove J, Lottspeich F, Bail OL, Urban MB, Kourilsky P, Baeuerle PA and Israël A. . 1990 Cell 62: 1007–1018.
Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt H, Chen C-H, Rosen CA and Stewart CL. . 1996 Mol. Cell. Biol. 16: 2341–2349.
Lenardo M and Siebenlist U. . 1994 Immunol. Today 15: 145–147.
Lernbecher T, Kistler B and Wirth T. . 1994 EMBO J. 13: 4060–4069.
Li Z and Nabel GJ. . 1997 Mol. Cell. Biol. 17: 6184–6190.
Liptay S, Schmid RM, Nabel EG and Nabel GJ. . 1994 Mol. Cell. Biol. 14: 7695–7703.
Lux SE John KM and Bennett V. . 1990 Nature 344: 36–42.
McKinsey TA, Brockman JA, Scherer DC, Al-Murrani SW, Green PL and Ballard DW. . 1996 Mol. Cell. Biol. 16: 2083–2090.
Mercurio F, Didonato J, Rosette C and Karin M. . 1992 DNA Cell Biol. 11: 523–537.
Mercurio F, DiDonato JA, Rosette C and Karin M. . 1993 Genes Dev. 7: 705–718.
Miyamoto S and Verma IM. . 1995 Adv. Cancer Res. 66: 255–292.
Nakshatri H, Bhat-Naahshatri P, Martin DA, Goulet Jr RJ and Sledge Jr GW. . 1997 Mol. Cell. Biol. 17: 3629–3639.
Neri A, Chang C-C, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RSK and Dalla-Favera R. . 1991 Cell 67: 1075–1087.
Nolan GP, Fujita T, Bhatia K, Huppi C, Liou H-C, Scott ML and Baltimore D. . 1993 Mol. Cell. Biol. 13: 3557–3566.
Oswald F, Liptay S, Adler G and Schmid RM. . 1998 Mol. Cell. Biol. 18: 2077–2088.
Palombella VJ, Rando OJ, Goldberg AL and Maniatis T. . 1994 Cell 78: 773–785.
Ray A, Prefontaine KE and Ray P. . 1994 J. Biol. Chem. 269: 12940–12946.
Rice NR, MacKichan ML and Israël A. . 1992 Cell 71: 243–253.
Rodriguez MS, Wright J, Thompson D, Baleux F, Virelizier J-L, Hay RT and Arenzana-Seisdedos F. . 1996 Oncogene 12: 2425–2435.
Roff M, Thompson J, Rodriguez MS, Jacque J-M, Baleux F, Arenzana-Seisdedos F and Hay RT. . 1996 J. Biol. Chem. 271: 7844–7850.
Rousset R, Desbois C, Bantignies F and Jalinot P. . 1996 Nature 381: 328–331.
Scherer D, Brockman JA, Chen Z, Maniatis T and Ballard DW. . 1995 Proc. Natl. Acad. Sci. USA 92: 11259–11263.
Schmid RM, Perkins ND, Duckett CS, Andrews PC and Nabel GJ. . 1991 Nature 352: 733–736.
Siebenlist U. . 1997 Biochim. Biophys. Acta 1332: R7–R13.
Siebenlist U, Franzoso G and Brown K. . 1994 Annu. Rev. Cell. Biol. 10: 405–455.
Sovak MA, Bellas RE, Kim DW, Zanievski GJ, Rogers AE and Traish AM. . 1997 J. Clin. Invest. 100: 2952–2960.
Stein B and Yang MX. . 1995 Mol. Cell. Biol. 15: 4971–4979.
Sun S-C, Ganchi PA, Ballard DW and Greene WC. . 1993 Science 259: 1912–1915.
Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P and Ghosh S. . 1995 Cell 80: 573–582.
Traenckner EB-M, Pahl HL, Henkel T, Schmidt KN, Wilk S and Baeuerle PA. . 1995 EMBO J. 14: 2876–2883.
Traenckner EB-M, Wilk S and Baeuerle PA. . 1994 EMBO J. 13: 5433–5441.
Tran K, Merika M and Thanos D. . 1997 Mol. Cell. Biol. 17: 5386–5399.
Watanabe N, Iwamura T, Shinoda T and Fujita T. . 1997 EMBO J. 16: 3609–3620.
Weil R, Laurent-Winter C and Israël A. . 1997 J. Biol. Chem. 272: 9942–9949.
Whiteside ST, Epinat JC, Rice NR and Israël A. . 1997 EMBO J. 16: 1413–1426.
Zabel U, Henkel T, Dos Santo Silva M and Baeuerle PA. . 1993 EMBO J. 12: 201–211.
Acknowledgements
We thank Dr U Siebenlist (NIH, Bethesda, MD, USA) for the p50 and p52 anti-peptide antibodies, Dr K Wood (Freeman Hospital, Newcastle, UK) for the IκB-α monoclonal antibody Mad 10B, Dr N Rice (NCI, Frederick, USA) for c-Rel antibody, Dr J Brady (NIH, Bethesda, MD, USA) for the Tax antibody, Dr B van der Burg (Hubrecht Laboratory, Utrecht, Netherlands) for the 3xNF-κB(pIC)-tk-LUC plasmid, Dr Ghosh (Yale University, CT, USA) for the IκB-β cDNA, Dr J Koh (MGH Cancer Center, Charlestown, MA, USA) for the pCMV-CD20 expression plasmid and Professor Mareel (University of Ghent, Belgium) for the MCF7 A/Z cells. M-PM and VB are Research Associates at the National Fund for Scientific Research (Belgium). ED and VD are supported by Télévie and FRIA fellowships, respectively. This work has been supported by grants from the National Fund for Scientific Research (Belgium), Télévie (Belgium) and the Centre Anti Cancéreux (University of Liège, Belgium).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dejardin, E., Deregowski, V., Chapelier, M. et al. Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells. Oncogene 18, 2567–2577 (1999). https://doi.org/10.1038/sj.onc.1202599
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202599
Keywords
This article is cited by
-
UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells
Cellular Oncology (2021)
-
Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3
Oncogene (2018)
-
Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis
International Journal of Colorectal Disease (2010)
-
Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma
BMC Cancer (2009)
-
Identification of a potent herbal molecule for the treatment of breast cancer
BMC Cancer (2009)